Endostatin: A novel inhibitor of androgen receptor function in prostate cancer.

Saved in:
Bibliographic Details
Title: Endostatin: A novel inhibitor of androgen receptor function in prostate cancer.
Authors: Lee JH; Departments of Pathology and., Isayeva T; Departments of Pathology and., Larson MR; Department of Biological Chemistry, University of Michigan Medical Center, Ann Arbor, MI 48109., Sawant A; Departments of Pathology and., Cha HR; Departments of Pathology and., Chanda D; Departments of Pathology and., Chesnokov IN; Biochemistry and Molecular Genetics, University of Alabama, Birmingham, AL 35294; and., Ponnazhagan S; Departments of Pathology and pons@uab.edu.
Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2015 Feb 03; Vol. 112 (5), pp. 1392-7. Date of Electronic Publication: 2015 Jan 20.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1091-6490
DOI:10.1073/pnas.1417660112